Botox is getting some new friendly competition very shortly, actually next month. Xeomin which was approved by the FDA just this month in August will be hitting the cosmetic medical market officially in September. It was approved by the FDA to treat neuromuscular conditions like cervical dystonia blepharospasm and is not yet approved to treat […]